Immunotherapy has an immense and growing impact on medicine and society : vaccines against pandemics, monoclonal antibodies – the most successful class of drugs, breakthrough cures of cancer and autoimmune diseases, and new hopes to fight degenerative diseases.
As immunologists and serial entrepreneurs, we contributed, at our small individual scale, to this biopharmaceutical revolution driven by immunology.
We now join forces at Remora Biotech to leverage our entrepreneurial experience and, thanks to our supporting investors, to scale-up our ability to nurture and develop innovative life-changing immunotherapies.
With our growing team and network of academic partners, business-oriented scientists, patent experts, drug developers and finance professionals, we create, finance, and manage a portfolio of daughter companies from discovery to clinical proof-of-concept. We aim at maximizing their odds of success and their strategic value for pharma partners while keeping capital efficient.
Investors keen to gain exposure to this high-growth and high-impact sector, under the leadership of seasoned entrepreneurs, may become a shareholder of Remora Biotech and co-invest in our daughter companies.
Company Details
- Employees
- 16
- Founded
- -
- Address
- Rue Du Petit-Chêne 12, Lausanne,1003,switzerland
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- remora-capital.ch
- Keywords
- oncology, immunology, biotech, pharma, digital health, anti-aging, Immunotherapy, botox, venture capital, cancer, medtech.
- HQ
- Lausanne
Remora Biotech Questions
Remora Biotech's website is remora-capital.ch
Remora Biotech's LinkedIn profile is https://ch.linkedin.com/company/remora-biotech
Remora Biotech has
16 employees.
View email and phone details for 16
employees at Remora Biotech.
Remora Biotech's industry is
Venture Capital and Private Equity Principals
Remora Biotech's top competitors are
Activen Sa,
Remora,
Fastox Pharma Sa,
Glycocalyx Therapeutics Ag,
Antion Biosciences Sa,
Cellula Therapeutics Sa,
Ogd2 Pharma,
Lunaphore (A Bio-Techne Brand),
Xenothera,
Geneva Biotech.
Remora Biotech's categories are Venture Capital and Private Equity Principals
Remora Biotech's founding year is 2010
